House of Representatives considers patent law to lower drug prices

By Hannah Albarazi (September 20, 2024, 10:17 p.m. EDT) — The U.S. House of Representatives is expected soon to consider a bill that has already passed the Senate that could streamline patent litigation by limiting the number of patents biologic drug makers can assert on biosimilar drugs….

Law360 is there, so you are too.

With a Law360 subscription, you'll always be up to date on current legal issues, trends and developments so you can act quickly and confidently. Over 200 articles are published daily on more than 60 topics, industries, legal areas and practice areas.

A Law360 subscription includes features such as

• Daily newsletter
• Expert analysis
• MobileApp
• Advanced search options
• Information about the judge
• Real-time alerts
• Over 450,000 searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.